Portfolio map · Private equity · United States

Vivo Capital portfolio map

98 startups Vivo Capital has backed in rounds we track, since 2014, grouped by their main sector. Together they have raised $17B; Vivo Capital led at least one round in 1 of them. The biggest sector is Biotech, with 68 companies.

98startups backed
5sectors
$17Braised between them
Biotechbiggest sector

Vivo Capital's investor profile

Biotech

68

+44 more

Pharma

17

Healthtech

7

Agtech

3

AI

3

Segment by segment

Biotech

68 startups · $11B raised

  1. CelcuityCelcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.United States$1.0B
  2. Candid TherapeuticsCandid Therapeutics was a clinical-stage biotechnology company based in San Diego, California, founded in 2024.United States$875M
  3. Terns PharmaceuticalsTerns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden.United States$730M
  4. Legend BiotechLegend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.United States$576M
  5. CTCidara TherapeuticsCidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.United States$463M
  6. Immunic TherapeuticsImmunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.United States$400M
  7. Trevi TherapeuticsTrevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.United States$386M
  8. Passage BioPassage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.United States$380M

Pharma

17 startups · $2.3B raised

  1. Zenas BioPharmaZenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.United States$420M
  2. AllakosAllakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.United States$294M
  3. Compass TherapeuticsCompass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.United States$257M
  4. Harmony BiosciencesHarmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.United States$248M
  5. ORIC PharmaceuticalsORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.United States$248M
  6. Poseida TherapeuticsPoseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.United States$217M
  7. Tarsus PharmaceuticalsTarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.United States$125M
  8. Mereo BiopharmaMereo is a new UK-based speciality biopharmaceutical company.United Kingdom$92M

Healthtech

7 startups · $2.2B raised

  1. Revolution MedicinesRevolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.United States$1.7B
  2. TricidaTricida operates in the healthcare industry focusing on pharmaceutical business.United States$327M
  3. Kinaset TherapeuticsAt Kinaset Therapeutics, we intend to develop novel respiratory therapeutics that can positively impact people affected by intractUnited States$103M
  4. NeocisNeocis is a medical technology company based in Miami, Florida, that specializes in robotic-assisted solutions for the dental induUnited States$52M
  5. Neumirna TherapeuticsNeumirna Therapeutics is a biotechnology company based in Copenhagen, founded in 2020.Denmark$21M
  6. AerobiotixAerobiotix is a privately held company specializing in the development and manufacture of proprietary environmental management devices.United States$10M
  7. PositrigoPositrigo AG is a Swiss medical device company based in Zürich, founded in 2018 as a spin-off from ETH Zurich.Switzerland$8.5M

Agtech

3 startups · $138M raised

  1. PProviviUnited States$124M
  2. MiiMOSAMiiMOSA is a leading European crowdfunding platform focused on financing the sustainable transition in agriculture, food, and energy sectors.France$8.9M
  3. AtekkaAtekka is a French insurance company specializing in agricultural insurance.France$4.9M

AI

3 startups · $553M raised

  1. Alto NeuroscienceAlto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.United States$270M
  2. TebraTebra Technologies, Inc.United States$250M
  3. HistoWizHistoWiz provides automated histopathology for biomedical researchers.United States$33M

How this map is made. Every startup here has raised money in a round we track that names Vivo Capital as an investor, the first in 2014. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Private equity · United StatesGaingels493 startups · 12 sectors · $40BPrivate equity · United StatesGoldman Sachs294 startups · 12 sectors · $163BPrivate equity · United StatesPioneer Fund289 startups · 12 sectors · $5.9BPrivate equity · United StatesRA Capital Management264 startups · 5 sectors · $48BPrivate equity · United StatesOrbiMed221 startups · 4 sectors · $34BPrivate equity · United StatesCormorant Asset Management123 startups · 3 sectors · $25B

Raising from investors like Vivo Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps